GSK, CSMA Pilot Materials Analysis for Anti-Counterfeiting

CSMA, an industry expert in materials analysis, has developed a method for detecting counterfeit drugs which could revolutionize detection practice in the pharmaceutical industry.
May 5, 2006

For more information on CSMA's anticounterfeiting efforts, go to www.ceram.com/csma-solution.htm.

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates

Related

Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Sponsored